Institutional investors hold a majority ownership of JNJ through the 68.10% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABERDEEN ASSET INVESTMENTS LTD. Bought 225.1 Thousand shares of Johnson & Johnson
HANDELSBANKEN FONDER AB Bought 151.2 Thousand shares of Johnson & Johnson
ANIMA SGR SPA Bought 140.2 Thousand shares of Johnson & Johnson